Search

everythinglearnresearchcommunity

for

Search:↓

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Black women with CCCA are more likely to have uterine fibroids.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

EFFC might be common but underreported.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Accurate diagnosis of EFFC is crucial for effective counseling and cosmetic care.

The patient has frontal fibrosing alopecia (FFA).

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.